Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2019 1
2020 5
2021 15
2022 3
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC-current state and future directions.
Eze C, Schmidt-Hegemann NS, Sawicki LM, Kirchner J, Roengvoraphoj O, Käsmann L, Mittlmeier LM, Kunz WG, Tufman A, Dinkel J, Ricke J, Belka C, Manapov F, Unterrainer M. Eze C, et al. Among authors: mittlmeier lm. Eur J Nucl Med Mol Imaging. 2021 Nov;48(12):3975-3989. doi: 10.1007/s00259-021-05211-8. Epub 2021 Mar 24. Eur J Nucl Med Mol Imaging. 2021. PMID: 33760957 Free PMC article. Review.
Advanced Molecular Imaging in Histologically Verified Metanephric Adenoma.
Mittlmeier LM, Unterrainer M, Todica A, Clevert DA, Cyran CC, Schmoeckel E, Rodler S, Bartenstein P, Stief CG, Ilhan H, Staehler M. Mittlmeier LM, et al. Urology. 2020 Jun;140:e10-e11. doi: 10.1016/j.urology.2020.02.025. Epub 2020 Apr 5. Urology. 2020. PMID: 32171695
First Clinical Results for PSMA-Targeted α-Therapy Using 225Ac-PSMA-I&T in Advanced-mCRPC Patients.
Zacherl MJ, Gildehaus FJ, Mittlmeier L, Böning G, Gosewisch A, Wenter V, Unterrainer M, Schmidt-Hegemann N, Belka C, Kretschmer A, Casuscelli J, Stief CG, Unterrainer M, Bartenstein P, Todica A, Ilhan H. Zacherl MJ, et al. Among authors: mittlmeier l. J Nucl Med. 2021 May 10;62(5):669-674. doi: 10.2967/jnumed.120.251017. Epub 2020 Oct 2. J Nucl Med. 2021. PMID: 33008928 Free article.
PSMA PET Imaging in Glioblastoma: A Preclinical Evaluation and Theranostic Outlook.
Kirchner MA, Holzgreve A, Brendel M, Orth M, Ruf VC, Steiger K, Pötter D, Gold L, Unterrainer M, Mittlmeier LM, Barci E, Kälin RE, Glass R, Lindner S, Kaiser L, Maas J, von Baumgarten L, Ilhan H, Belka C, Notni J, Bartenstein P, Lauber K, Albert NL. Kirchner MA, et al. Among authors: mittlmeier lm. Front Oncol. 2021 Nov 17;11:774017. doi: 10.3389/fonc.2021.774017. eCollection 2021. Front Oncol. 2021. PMID: 34869017 Free PMC article.
Dosimetry and optimal scan time of [18F]SiTATE-PET/CT in patients with neuroendocrine tumours.
Beyer L, Gosewisch A, Lindner S, Völter F, Mittlmeier LM, Tiling R, Brendel M, Cyran CC, Unterrainer M, Rübenthaler J, Auernhammer CJ, Spitzweg C, Böning G, Gildehaus FJ, Jurkschat K, Wängler C, Wängler B, Schirrmacher R, Wenter V, Todica A, Bartenstein P, Ilhan H. Beyer L, et al. Among authors: mittlmeier lm. Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3571-3581. doi: 10.1007/s00259-021-05351-x. Epub 2021 Apr 29. Eur J Nucl Med Mol Imaging. 2021. PMID: 33928401 Free PMC article.
68Ga-EMP-100 PET/CT-a novel ligand for visualizing c-MET expression in metastatic renal cell carcinoma-first in-human biodistribution and imaging results.
Mittlmeier LM, Todica A, Gildehaus FJ, Unterrainer M, Beyer L, Brendel M, Albert NL, Ledderose ST, Vettermann FJ, Schott M, Rodler S, Marcon J, Ilhan H, Cyran CC, Stief CG, Staehler M, Bartenstein P. Mittlmeier LM, et al. Eur J Nucl Med Mol Imaging. 2022 Apr;49(5):1711-1720. doi: 10.1007/s00259-021-05596-6. Epub 2021 Oct 28. Eur J Nucl Med Mol Imaging. 2022. PMID: 34708249 Free PMC article.
22 results